Skip to main content
Media Coverage

Enveric Receives Patent For Psilocybin Molecules [Green Market Report]

By September 20, 2023No Comments

Enveric Biosciences (NASDAQ: ENVB) announced that the United States Patent and Trademark Office issued U.S. Patent No. 11,752,130, titled “Carboxylated Psilocybin Derivatives and Methods of Using,” pertaining to the Company’s EVM301 Series of molecules being developed as potential treatments for mental health disorders.

Full Story